Dr Nathan Benaich is an investor, a technologist and a former scientist. He has done his PhD at the CSCRM and now works with companies that solve challenging and valuable problems using breakthrough technologies including, but not limited to, artificial intelligence.

Dr Nathan Benaich is an investor, a technologist and a former scientist. He has done his PhD at the CSCRM and now works with companies that solve challenging and valuable problems using breakthrough technologies including, but not limited to, artificial intelligence.

http://cambridge-stem-cell-institute.appstor.io

http://cambridge-stem-cell-institute.appstor.io

Episode 18 - Chris Baker by StemCells@Lunch Digested

Episode 18 - Chris Baker by StemCells@Lunch Digested

Dr Edouard Hanezzo is a postdoctoral researcher with Prof Ben Simons at The University of Cambridge. Their research applies methods of non-equilibrium statistical mechanics and population dynamics to lineage tracing studies to investigate mechanisms of stem cell fate in development and maintenance. If you like this episode leave us a review on iTunes and email us on [email protected]

Dr Edouard Hanezzo is a postdoctoral researcher with Prof Ben Simons at The University of Cambridge. Their research applies methods of non-equilibrium statistical mechanics and population dynamics to lineage tracing studies to investigate mechanisms of stem cell fate in development and maintenance. If you like this episode leave us a review on iTunes and email us on [email protected]

Dr Mathieu Bollen is a Group leader in the Laboratory of Biosignaling & Therapeutics and Chair of Department of Cellular and Molecular Medicine at the University of Leuven, Belgium. In his lab they investigate cellular signal transduction pathways at the molecular level, with the major goal of identifying and developing novel biomarkers or therapeutic targets for human diseases.

Dr Mathieu Bollen is a Group leader in the Laboratory of Biosignaling & Therapeutics and Chair of Department of Cellular and Molecular Medicine at the University of Leuven, Belgium. In his lab they investigate cellular signal transduction pathways at the molecular level, with the major goal of identifying and developing novel biomarkers or therapeutic targets for human diseases.